Our expert teams can help with process and analytical development at any stage.
We have extensive expertise in designing processes, developing systems that are streamlined and more efficient, and optimising existing processes to increase yield and decrease timescales.
We work with a range of different vaccine platforms. So you can test out processes on new platforms, expression systems, bioreactors, fermenters and purification steps, and scale up when appropriate.
Alongside process development, our specialist analytical development teams will develop systems to ensure that your vaccine has the correct identity, purity, potency and quantity.
Our analytical development capabilities include:
- Peptide mapping and Intact mass
- ELISA/ELISpot assays
- UPLC including SEC-MALS
- Protein profile (SDS-PAGE, WB, IEF)
- Karl Fischer water determination
- Dynamic Light Scattering
- Handling biologicals to safety level 2 and performing bioassays
Meet the expert
Martin Smith, PhD
VMIC Head of Manufacturing Science and Technology, and Process and Analytical Development
Martin brings to VMIC vast experience in technical, managerial and leadership roles across early and late phase bioprocess development and validation projects in Biopharma R&D & GMP operations. He has experience in cell and gene therapy facility design, laboratory start-up, and process development and manufacturing.